Non‐invasive foetal <scp> <i>RhD</i> </scp> genotyping: A strategy for rationalizing anti‐D immunoglobulin prophylaxis in <scp>RhD</scp> ‐negative pregnant women at the Hospital Italiano de Buenos Aires
The results of the study reveal that the strategy of combining three RhD exons to determine foetal RhD status is reliable, with 100% accuracy. Prenatal diagnosis showed that 32.5% of newborns were RhD negative. Using this strategy, a decrease in the use of anti-D immunoglobulin is expected.
Authors
- Horacio Aiello (ORCID: https://orcid.org/0000-0003-0824-3392)
- Lucas Otaño (ORCID: https://orcid.org/0000-0003-0172-1304)
- Paula González Hermida (ORCID: https://orcid.org/0009-0009-2502-6729)
- Pablo Javier Camino
- Leandro Daniel Burgos Pratx (ORCID: https://orcid.org/0000-0003-1615-2327)
- Diego Mario Santoro (ORCID: https://orcid.org/0000-0003-1400-0899)
- César Meller (ORCID: https://orcid.org/0000-0001-5686-667X)
- Hernan Jorge Garcia Rivello
- C Gamboa
Institutions
- Hospital Italiano de Buenos Aires (AR)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/vox.70158
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00